In other words, NDV can enhance the capability of CTLA-4 inhibitor on conquering tumor metastasis and improving long-term survival of mice with colon cancer or melanoma, by increasing tumor infiltration with activated lymphocytes, and systemic tumor inflammatory effects [66]. Here, CTLA4 is linked to melanoma.